Literature DB >> 32557132

Antenatal Admissions Among Women with Opioid-Affected and Non-Opioid-Affected Deliveries.

Laura J Faherty1,2, Ashley M Kranz3, Joshua Russell-Fritch4, Teague Ruder5, Stephen W Patrick6,7,8,9,5, Bradley D Stein5,10.   

Abstract

OBJECTIVES: (1) To compare the prevalence of antenatal admissions and mean length of stay among women with opioid-affected and non-opioid-affected deliveries; (2) examine predictors of admission; and (3) describe the most common discharge diagnoses in each group.
METHODS: Using data from seven states in the State Inpatient Databases for varying years between 2009 and 2014, delivery hospitalizations among women 18 years of age and older were identified and classified as opioid-affected or non-opioid-affected. Antenatal admissions were linked to deliveries. The antenatal admission ratio and mean length of stay for each group were calculated; the percentage of deliveries in each group with no, any, one, two, or three or more antenatal admissions were compared with t-tests. Logistic regression models estimated odds of any antenatal admission, stratified by opioid-affected and non-opioid-affected deliveries. Frequencies were tabulated for the ten most common discharge diagnoses in each group.
RESULTS: Of 2,684,970 deliveries, 14,765 were opioid-affected. Admissions among women with opioid-affected deliveries were more prevalent (26.4 per 100 deliveries) compared to 6.7 among women with non-opioid-affected deliveries and were associated with a 1.5-day longer mean length of stay. The presence of a behavioral health condition was associated with higher odds of antenatal admission in both groups, with a particularly strong association among women with opioid-affected deliveries. Six of the ten most common diagnoses for admissions prior to opioid-affected deliveries were behavioral health-related. CONCLUSIONS FOR PRACTICE: These results highlight the importance of addressing the large burden of behavioral health conditions among pregnant women, especially those with opioid dependence and abuse.

Entities:  

Keywords:  Antenatal admission; Behavioral health; Mental health; Opioid use disorder; Substance use disorder

Mesh:

Substances:

Year:  2020        PMID: 32557132      PMCID: PMC7423739          DOI: 10.1007/s10995-020-02959-7

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  29 in total

1.  Pregnancy-associated hospitalizations in the United States, 1999-2000.

Authors:  Stephen J Bacak; William M Callaghan; Patricia M Dietz; Chadd Crouse
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

2.  Hospitalization for pregnancy complications, United States, 1986 and 1987.

Authors:  A L Franks; J S Kendrick; D R Olson; H K Atrash; A F Saftlas; M Moien
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

3.  Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.

Authors:  Vanessa L Short; Dennis J Hand; Lauren MacAfee; Diane J Abatemarco; Mishka Terplan
Journal:  J Subst Abuse Treat       Date:  2018-04-06

4.  The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.

Authors:  Michelle Tuten; Sarah H Heil; Kevin E O'Grady; Heather Fitzsimons; Margaret S Chisolm; Hendrée E Jones
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

5.  Hospitalizations during pregnancy among managed care enrollees.

Authors:  Julie A Gazmararian; Ruth Petersen; Denise J Jamieson; Laura Schild; Melissa M Adams; Anjali D Deshpande; Adele L Franks
Journal:  Obstet Gynecol       Date:  2002-07       Impact factor: 7.661

6.  Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.

Authors:  Laura J Faherty; Meredith Matone; Molly Passarella; Scott Lorch
Journal:  Matern Child Health J       Date:  2018-06

7.  Antenatal hospitalization among enlisted servicewomen, 1987-1990.

Authors:  M M Adams; F E Harlass; A P Sarno; J A Read; J S Rawlings
Journal:  Obstet Gynecol       Date:  1994-07       Impact factor: 7.661

8.  Support during pregnancy for women at increased risk of low birthweight babies.

Authors:  Christine E East; Mary A Biro; Suzanne Fredericks; Rosalind Lau
Journal:  Cochrane Database Syst Rev       Date:  2019-04-01

9.  Obstetric Outcomes and Delivery-Related Health Care Utilization and Costs Among Pregnant Women With Multiple Chronic Conditions.

Authors:  Lindsay K Admon; Tyler N A Winkelman; Michele Heisler; Vanessa K Dalton
Journal:  Prev Chronic Dis       Date:  2018-02-08       Impact factor: 2.830

10.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

View more
  1 in total

1.  Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure.

Authors:  Laura J Faherty; Sara Heins; Ashley M Kranz; Bradley D Stein
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.